ATE150301T1 - Aminoalkanesulfonsäurederivate und pharmazeutische zusammensetzungen davon zur prävention oder behandlung von herzerkrankungen - Google Patents

Aminoalkanesulfonsäurederivate und pharmazeutische zusammensetzungen davon zur prävention oder behandlung von herzerkrankungen

Info

Publication number
ATE150301T1
ATE150301T1 AT91810580T AT91810580T ATE150301T1 AT E150301 T1 ATE150301 T1 AT E150301T1 AT 91810580 T AT91810580 T AT 91810580T AT 91810580 T AT91810580 T AT 91810580T AT E150301 T1 ATE150301 T1 AT E150301T1
Authority
AT
Austria
Prior art keywords
preventing
heart diseases
treating heart
pharmaceutical compositions
acid derivatives
Prior art date
Application number
AT91810580T
Other languages
English (en)
Inventor
Kunihiko Higashiura
Kazuharu Ienaga
Masao Hattori
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2192575A external-priority patent/JP3070687B2/ja
Priority claimed from JP2223807A external-priority patent/JP3068841B2/ja
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Application granted granted Critical
Publication of ATE150301T1 publication Critical patent/ATE150301T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
AT91810580T 1990-07-19 1991-07-18 Aminoalkanesulfonsäurederivate und pharmazeutische zusammensetzungen davon zur prävention oder behandlung von herzerkrankungen ATE150301T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2192575A JP3070687B2 (ja) 1990-07-19 1990-07-19 心疾患治療剤
JP2223807A JP3068841B2 (ja) 1990-08-23 1990-08-23 アミノアルカンスルホン酸誘導体を有効成分として含有する心疾患治療剤

Publications (1)

Publication Number Publication Date
ATE150301T1 true ATE150301T1 (de) 1997-04-15

Family

ID=26507401

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91810580T ATE150301T1 (de) 1990-07-19 1991-07-18 Aminoalkanesulfonsäurederivate und pharmazeutische zusammensetzungen davon zur prävention oder behandlung von herzerkrankungen

Country Status (5)

Country Link
US (1) US5430052A (de)
EP (1) EP0467856B1 (de)
AT (1) ATE150301T1 (de)
DE (1) DE69125216T2 (de)
ES (1) ES2100222T3 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
EP1018877A4 (de) * 1995-10-17 2000-08-09 Dovetail Technologies Inc Zell-, knochenmark- und immunistimulanzen mit niedrigerm molekulargewicht
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
US7309721B2 (en) 2002-03-01 2007-12-18 Merck + Co., Inc. Aminoalkylphosphonates and related compounds as Edg receptor agonists
US6774261B2 (en) * 2002-08-29 2004-08-10 Buffers & Biochemicals Corporation High purity amino-organosulfonic acid zwitterionic compositions
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
WO2005000406A2 (en) * 2003-06-23 2005-01-06 Neurochem (International) Limited Treatment of amyloid- and epileptogenesis-associated diseases
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
BRPI0517790A (pt) * 2004-11-12 2008-10-21 Neurochem Int Ltd métodos e composições fluoradas para tratar doenças relacionadas à amilóide
EP1817305A2 (de) * 2004-11-16 2007-08-15 Neurochem (International) Limited Verbindungen zur behandlung von cns- und amyloidassoziierten krankheiten
EP1836161B1 (de) 2004-12-22 2016-07-20 BHI Limited Partnership Verfahren und zusammensetzungen zur behandlung von amyloidassoziierten krankheiten
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
EP1968561B8 (de) * 2005-12-22 2010-10-20 Kiacta Sàrl Behandlung von diabetischer nephropathie
US20070261933A1 (en) * 2006-04-26 2007-11-15 Scott C W Conveyor roller assembly and conveyor roller insert
PT3851447T (pt) 2006-10-12 2023-12-11 Bellus Health Inc Métodos, compostos, composições e veículos para administrar ácido 3-amino-1-propanossulfónico
AU2007337806A1 (en) * 2006-12-22 2008-07-03 Bellus Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
CA2733390A1 (en) * 2008-08-01 2010-02-04 Bioxiness Pharmaceuticals, Inc. Methionine analogs and methods of using same
FR2961392A1 (fr) * 2010-06-17 2011-12-23 Oreal Utilisation de derives d'acide amine comme agent de traitement de la transpiration humaine ; nouveaux composes ; compositions les contenant

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3189M (fr) * 1963-07-13 1965-03-15 Pharmaco Biolog Soc Médicament a base d'acide 2-amino-éthanesulfonique.
NL6708311A (de) * 1966-06-18 1967-12-19
JPS494210B1 (de) * 1970-06-17 1974-01-31
CH665645A5 (fr) * 1981-07-09 1988-05-31 Michel Flork Derives de dipeptides et leur procede de preparation.
JPS5852253A (ja) * 1981-09-21 1983-03-28 Tanabe Seiyaku Co Ltd Ρ−ヒドロキシフエニルグリシン・α−フエニルエタンスルホン酸塩及びその光学分割法
US5011983A (en) * 1987-01-23 1991-04-30 Minnesota Mining And Manufacturing Company Preparation and reactions of omega-halosulfonyl perfluoroalkanesulfonates
JPH0713052B2 (ja) * 1987-02-27 1995-02-15 日本臓器製薬株式会社 ジペプチド
JPH07103100B2 (ja) * 1987-02-27 1995-11-08 日本臓器製薬株式会社 新規ジペプチド
JP2733511B2 (ja) * 1988-10-22 1998-03-30 日本臓器製薬株式会社 新規アミノアルカン誘導体
JPH02243619A (ja) * 1989-03-15 1990-09-27 Green Cross Corp:The 抗血小板凝集剤
JP2857461B2 (ja) * 1990-03-28 1999-02-17 日本臓器製薬株式会社 ジペプチド化合物

Also Published As

Publication number Publication date
ES2100222T3 (es) 1997-06-16
EP0467856A2 (de) 1992-01-22
EP0467856A3 (en) 1992-10-14
DE69125216T2 (de) 1997-09-25
EP0467856B1 (de) 1997-03-19
DE69125216D1 (de) 1997-04-24
US5430052A (en) 1995-07-04

Similar Documents

Publication Publication Date Title
ATE150301T1 (de) Aminoalkanesulfonsäurederivate und pharmazeutische zusammensetzungen davon zur prävention oder behandlung von herzerkrankungen
DE68914292T2 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
ES2040242T3 (es) Composiciones farmaceuticas.
DE69019111T2 (de) Ascorbinsäure-Tocopheryl-Phosphatdiester zur Hemmung der Maillard-Reaktion.
DE69428325D1 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen Derivaten zur Herstellung eines Medikaments zur Hemmung der Angiogenese und angiogene Krankheiten
DE69029693T2 (de) Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz
DE69501359T2 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
ATE48001T1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate.
PT1080081E (pt) Derivados do benzofuraxano e a sua utilizacao no tratamento da angina de peito
DE69418744D1 (de) Verwendung von Pregnanderivaten zur Behandlung von Tumoren
ATE169217T1 (de) Verwendung von furanonderivaten zur vorbeugung oder behandlung von autoimmunkrankheiten
PT92047A (pt) Processo para a preparacao de derivados de nitroxialquilaminas com a funcao amida, de compostos intermediarios e de composicoes farmaceuticas que as contem
DE69001004D1 (de) Zusammensetzung gegen leberkrankheiten.
DK0556813T3 (da) Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler
ZA891769B (en) Heterocyclic compounds
ES2027492A6 (es) Procedimiento de preparacion de nuevos derivados dihidropirimidotiazinos y de sus sales de adicion acidas farmaceuticamente aceptables.
IT1248525B (it) Derivati dell'eseridina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties